title: Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice.
abstract: Medulloblastoma is the most common malignant pediatric brain tumor. Current treatment is associated with major long-term side effects; therefore, new nontoxic therapies, targeting specific molecular defects in this cancer, need to be developed. We use a mouse model of medulloblastoma to show that inhibition of the Sonic Hedgehog (Shh) pathway provides a novel therapy for medulloblastoma. A small molecule inhibitor of the Shh pathway, HhAntag, blocked the function of Smoothened in mice with medulloblastoma. This resulted in suppression of several genes highly expressed in medulloblastoma, inhibition of cell proliferation, increase in cell death and, at the highest dose, complete eradication of tumors. Long-term treatment with HhAntag prolonged medulloblastoma-free survival. These findings support the development of Shh antagonists for the treatment of medulloblastoma.
authors.affiliation: Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
authors.forename: Justyna T
authors.initials: JT
authors.lastname: Romer
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Kimura
authors.forename: Susan
authors.initials: S
authors.lastname: Magdaleno
authors.forename: Ken
authors.initials: K
authors.lastname: Sasai
authors.forename: Christine
authors.initials: C
authors.lastname: Fuller
authors.forename: Helen
authors.initials: H
authors.lastname: Baines
authors.forename: Michele
authors.initials: M
authors.lastname: Connelly
authors.forename: Clinton F
authors.initials: CF
authors.lastname: Stewart
authors.forename: Stephen
authors.initials: S
authors.lastname: Gould
authors.forename: Lee L
authors.initials: LL
authors.lastname: Rubin
authors.forename: Tom
authors.initials: T
authors.lastname: Curran
mesh_terms: D000818:Animals; D001932:Brain Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D002455:Cell Division; D018572:Disease-Free Survival; D004305:Dose-Response Relationship, Drug; D053823:Hedgehog Proteins; D051741:Kruppel-Like Transcription Factors; D008527:Medulloblastoma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D015398:Signal Transduction; D000072086:Smoothened Receptor; D015534:Trans-Activators / Q000037:antagonists & inhibitors*; D014157:Transcription Factors / Q000378:metabolism; D014407:Tumor Cells, Cultured; D000071676:Zinc Finger Protein GLI1
chemical_list: C498520:Gli1 protein, mouse; D053823:Hedgehog Proteins; D051741:Kruppel-Like Transcription Factors; D043562:Receptors, G-Protein-Coupled; C465570:Shh protein, mouse; C491022:Smo protein, mouse; D000072086:Smoothened Receptor; D015534:Trans-Activators; D014157:Transcription Factors; D000071676:Zinc Finger Protein GLI1